Murdo Gordon Amgen Inc (AMGN) insider trading activity

Murdo Gordon is EVP, Global Commercial Ops of AMGEN INC. Currently has a direct ownership of 52,674 shares of AMGN, which is worth approximately $14 Million. The most recent transaction as insider was on May 07, 2024, when has been sold 3,529 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.7K

0% 3M change

18.88% 12M change

Total Value Held $14 Million

Murdo Gordon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 07 2024	BUY Grant, award, or other acquisition	-	3,529 Added 6.28%	52,674 Common Stock
May 05 2024	SELL Payment of exercise price or tax liability	$207,007 $311.29 p/Share	665 Reduced 1.34%	49,145 Common Stock
May 02 2024	SELL Payment of exercise price or tax liability	$210,246 $277.37 p/Share	758 Reduced 1.5%	49,810 Common Stock
Apr 30 2024	SELL Payment of exercise price or tax liability	$208,114 $276.38 p/Share	753 Reduced 1.47%	50,568 Common Stock
Mar 18 2024	SELL Payment of exercise price or tax liability	$1,737,169 $268.87 p/Share	6,461 Reduced 11.18%	51,321 Common Stock
Mar 06 2024	BUY Grant, award, or other acquisition	-	12,924 Added 18.33%	57,569 Common Stock
Aug 10 2023	SELL Open market or private sale	$2,508,305 $262.43 p/Share	9,558 Reduced 17.74%	44,308 Common Stock
May 05 2023	SELL Payment of exercise price or tax liability	$144,467 $231.89 p/Share	623 Reduced 1.14%	53,866 Common Stock
May 03 2023	SELL Payment of exercise price or tax liability	$202,698 $235.97 p/Share	859 Reduced 1.55%	54,489 Common Stock
May 02 2023	BUY Grant, award, or other acquisition	-	4,237 Added 7.11%	55,348 Common Stock
Apr 30 2023	SELL Payment of exercise price or tax liability	$174,530 $239.74 p/Share	728 Reduced 1.4%	51,111 Common Stock
Mar 17 2023	SELL Payment of exercise price or tax liability	$933,119 $234.57 p/Share	3,978 Reduced 7.13%	51,839 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	7,947 Added 12.5%	55,621 Common Stock
Aug 22 2022	SELL Bona fide gift	-	400 Reduced 0.84%	47,484 Common Stock
May 05 2022	SELL Payment of exercise price or tax liability	$142,368 $236.1 p/Share	603 Reduced 1.25%	47,784 Common Stock
May 03 2022	SELL Payment of exercise price or tax liability	$186,583 $230.92 p/Share	808 Reduced 1.64%	48,387 Common Stock
May 02 2022	BUY Grant, award, or other acquisition	-	4,330 Added 8.09%	49,195 Common Stock
Mar 18 2022	SELL Payment of exercise price or tax liability	$1,178,121 $235.86 p/Share	4,995 Reduced 10.02%	44,865 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	9,989 Added 16.74%	49,682 Common Stock
Nov 02 2021	SELL Payment of exercise price or tax liability	$1,171,677 $209.79 p/Share	5,585 Reduced 12.36%	39,602 Common Stock
May 03 2021	SELL Payment of exercise price or tax liability	$187,398 $239.64 p/Share	782 Reduced 1.71%	44,848 Common Stock
Apr 30 2021	BUY Grant, award, or other acquisition	-	4,172 Added 8.38%	45,630 Common Stock
Mar 19 2021	SELL Payment of exercise price or tax liability	$2,197,091 $244.42 p/Share	8,989 Reduced 17.82%	41,458 Common Stock
Mar 02 2021	BUY Grant, award, or other acquisition	-	17,989 Added 26.4%	50,159 Common Stock
Nov 02 2020	SELL Payment of exercise price or tax liability	$1,359,997 $216.94 p/Share	6,269 Reduced 16.37%	32,036 Common Stock

Also insider at

BMY

BRISTOL MYERS SQUIBB CO Healthcare

EVP, Chief Commercial Officer

Murdo Gordon

EVP, Global Commercial Ops

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMGN shares.

Notify only if

Value

Insider Trading

Get notified when an Amgen Inc insider buys or sells AMGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMGEN INC

Track Activities on AMGN

Account